Clinical Trial Detail

NCT ID NCT03069469
Title Study of DCC-3014 in Patients With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Indications

chronic lymphocytic leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

Advanced Solid Tumor

myelodysplastic syndrome

Therapies

DCC-3014

Age Groups: senior adult child

No variant requirements are available.